Skip to main content
. Author manuscript; available in PMC: 2017 Jan 7.
Published in final edited form as: Nanoscale. 2015 Oct 7;8(25):12504–12509. doi: 10.1039/c5nr05552k

Figure 5.

Figure 5

(a) Super enhanced delivery of gadofosveset, a protein-binding MRI contrast agent. Gadofosveset greatly and homogeneously enhances only post-NIR-PIT treated tumor 10 min after injection. Circles indicate tumors. (b) Super enhanced delivery of indocyanine green, a protein-binding NIR optical contrast agent. Indocyanine green only enhances NIR-PIT treated tumor 20 min after injection.